Andrea Orr has represented publicly traded companies in mergers and acquisitions valued at more than $11.7 billion and more than $8.8 billion in securities offerings and other corporate transactions. She also routinely advises clients on corporate and securities matters, primarily large public companies in the retail, healthcare and manufacturing industries.
Andrea’s practice primarily involves:
Formerly Vice President and Corporate Counsel at HealthSpring, Andrea worked to ensure the company’s compliance with SEC and NYSE rules and regulations.
American Health Lawyers Association (AHLA)
Health Enterprise Partners Invests in AxiaMed
Represented American Investment Funds I, LLC, parent company to American Tubing Arkansas, LLC, in its sale to Sanhua International, Inc.
Represented Standard Function Foods in its sale to a private bakery
Represented a healthcare private equity in its sale of Applied Pathways
Represented leading RCM provider in its sale to LLR Partners
Represented CHS in its $900 million secured notes tack-on offering
Represented CHS in its $2.2 billion secured notes offering
Represented CLARCOR Inc. (NYSE: CLC) in its acquisition by Parker Hannifin Corporation (NYSE: PH) for approximately $4.3 billion in cash
Represented CLARCOR Inc. in connection with its senior credit facility transactions, including most recently a $500 million senior unsecured revolving credit facility and a $200 million term loan facility led by Bank of America, N.A.
Represented Polaris Hospital Holdings, LLC and its majority private equity owner, HCP & Company, in the company’s sale to Acadia Healthcare Company, Inc.
Wake Forest Law Review (2004-2005)
Moot Court Board (2003-2005)